SLS International (AMEX:SLS) received a $5.00 target price from investment analysts at Maxim Group in a report released on Thursday. The brokerage currently has a “buy” rating on the biotechnology company’s stock.
Several other analysts have also weighed in on the company. Oppenheimer started coverage on SLS International in a report on Thursday, November 1st. They issued an “outperform” rating and a $13.00 price objective for the company. CIBC started coverage on SLS International in a report on Thursday, November 1st. They issued an “outperform” rating for the company. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. SLS International has a consensus rating of “Buy” and a consensus price target of $5.81.
SLS International (AMEX:SLS) last released its quarterly earnings results on Thursday, November 15th. The biotechnology company reported ($0.53) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.36) by ($0.17).
SLS International Company Profile
SLS international is a language services company which offers translations globally. The Company offers a range of services, including multilingual translations into all Spanish variants, localization, adaptation and content editing. It uses the mother-tongue linguists in order to meet the demanding standards.
Featured Article: Analyst Ratings
Receive News & Ratings for SLS International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SLS International and related companies with MarketBeat.com's FREE daily email newsletter.